• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The profit motive behind too much medical research.

出版信息

Origins. 2002 Apr 25;31(45):754-5.

PMID:12426702
Abstract

A conflict of interest in scientific and medical research "between the investigation and correct treatment of illness ... and the financial objective of making a profit" was addressed in a papal message to an April 5-6 international conference on conflicts of interest in science and medicine sponsored by the Polish Academy of Sciences. The Vatican released the papal message April 11, which was addressed as a letter to Archbishop Jozef Kowalczyk, apostolic nuncio to Poland. The pope said that "there is a risk that science-based businesses and health care structures can be set up not in order to provide the best possible care for people in accordance with their human dignity but in order to maximize profits and increase business, with a predictable lowering in the quality of service of those unable to pay." For example, the pope said, the pharmaceutical industry, "driven by the pursuit of profit and catering to what could be called 'medicine of desires' ... has favored research which as already placed on the world market products contrary to the moral good, including products which are not respectful of procreation and even suppress human life already conceived." The pope expressed concern about how priorities are set for pharmaceutical research, as well as about cost-containment imperatives in hospital medical care. His letter was written in English. The text follows.

摘要

相似文献

1
The profit motive behind too much medical research.
Origins. 2002 Apr 25;31(45):754-5.
2
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
3
[The origin of informed consent].[知情同意的起源]
Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27.
4
Industry-sponsored research.行业资助的研究。
Injury. 2008 Jun;39(6):666-80. doi: 10.1016/j.injury.2008.02.013.
5
[Procedures and methods of benefit assessments for medicines in Germany].[德国药品效益评估的程序和方法]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25.
6
[Medicine: conflicts of interest in research].[医学:研究中的利益冲突]
Rev Invest Clin. 2003 May-Jun;55(3):339-46.
7
Conflicts of interest in dermatology.皮肤科领域的利益冲突。
Acta Derm Venereol. 2006;86(6):485-97. doi: 10.2340/00015555-0191.
8
[Is the pharmaceutical industry really as bad as its reputation?].制药行业真的像其名声那么糟糕吗?
Wien Med Wochenschr. 2005 Nov;155(21-22):502-12. doi: 10.1007/s10354-005-0233-x.
9
Conflict of interest and its significance in science and medicine.利益冲突及其在科学和医学中的意义。
Natl Cathol Bioeth Q. 2002 Summer;2(2):315-7.
10
Alcohol research and the alcoholic beverage industry: issues, concerns and conflicts of interest.酒精研究与酒精饮料行业:问题、担忧及利益冲突。
Addiction. 2009 Feb;104 Suppl 1:34-47. doi: 10.1111/j.1360-0443.2008.02433.x.